N/A
N=86
Using Electrical Bioimpedance Assessments to Estimate Perioperative Total Body Water and Postoperative Fluid Need
Intestinal Cancer · Diverticulitis · Pancreatic Cancer · Gastroesophageal Reflux Disease
Bottom Line
View on ClinicalTrials.gov: NCT02200055 ↗Enrolled (actual)
86
Serious AEs
3.3%
Results posted
Aug 2018
Primary outcome: Primary: Bioimpedance Assessment — 0.53 ohms
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Bodystat Quadscan 4000 (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- United States Naval Medical Center, Portsmouth
- Primary completion
- Jul 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Bioimpedance Assessment |
0.59 | — |
| PRIMARY Bioimpedance Assessment |
0.59 | — |
| PRIMARY Bioimpedance Assessment |
0.59 | — |
| SECONDARY Percent Extracellular Water Volume |
0.32 | — |
| SECONDARY Percent Intracellular Water Volume |
0.30 | <0.01 sig |
| SECONDARY Percent Extracellular Water Volume |
0.32 | — |
| SECONDARY Percent Intracellular Water Volume |
0.30 | <0.01 sig |
| SECONDARY Daily Fluid Balance (Intakes and Outputs) |
1163.1 | — |
| SECONDARY Urine Output |
406.7 | — |
| SECONDARY Study Characteristics of Participants: Body Mass Index |
27 | — |
| SECONDARY American Society of Anaesthesiologists Physical Status Classification Scale |
2.2 | — |
| SECONDARY Amount of Intraoperative Fluids |
2472.6 | — |
Summary
Being able to accurately monitor patient bodily fluid levels during and after surgery is very important, as there are a number of complications that can arise if a patient's fluid levels become unbalanced, such as swelling within or pressure on various bodily organ systems. There are several different ways that physicians can monitor a patient's fluid balance during and after surgery, such as measuring the amount of urine output or the use of central venous catheters which measure the pressure in the veins entering the heart. Most of these techniques are invasive since they require tubes to be inserted into the body. A potential alternative would be to use a noninvasive technique such as electrical bioimpedance (BIA).
Bioimpedance assessments work by using small electrical currents that can accurately predict both the water surrounding the outside of cells in the body, as well as the total amount of water in the entire body. Electrical bioimpedance assessments have been used to estimate patient swelling following surgery (edema), to measure the volume of blood the heart is pumping out, as well as to calculate body fat percentages.
The goal of this study is to relate this technology to fluid shifts within the body that occur as a result of surgery, in particular, major intra-abdominal surgeries. By using bioimpedance during and after surgery, the investigators will compare the data collected with that calculated by using traditional measures of body fluid status, such as urine output and intraoperative blood loss. During the study, the bioimpedance monitors will not replace the standard bodily fluid monitors and will not interfere with their readings. Additionally, the electrical current produced by the bioimpedance monitors is too small for patients to feel and will not interfere with medical devices such as pacemakers.
Eligibility Criteria
Inclusion Criteria
- Patients having major intra-abdominal procedures under general anesthesia requiring hospitalization postoperatively during the initial recovery from surgery.
Exclusion Criteria
- Patients not having intra-abdominal procedures (ie. Thyroidectomy, open or laparoscopic inguinal hernia repair, excision of skin lesions, breast procedures)
- Patients having outpatient surgery
- Patients having laparoscopic cholecystectomies, laparoscopic or open appendectomies
- Patients having bariatric surgery (because the bioimpedance assessment technology has proven to be unreliable in obese populations)
- Morbidly obese patients (BMI >40)
- Unable to provide informed consent
- Pregnant women
Data sourced from ClinicalTrials.gov (NCT02200055). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.